Data / Drug companies / Clorazepate dipotassium
Clorazepate dipotassium: 8 companies and 25 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Clorazepate dipotassium is listed in the FDA National Drug Code Directory by 8 companies, with 25 products in commercial distribution. 25 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, and the newest product started marketing on September 30, 2025.
The request: Get every company that lists clorazepate dipotassium in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 8
- Products
- 25
- Generic (ANDA) products
- 25 (100.0%)
- Application numbers
- 4
- Controlled substance schedule
- Schedule IV
- Routes
- Oral
- openFDA record search
- api.fda.gov
Companies that list clorazepate dipotassium
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Aurolife Pharma, LLC | 6 | tablet | Generic drugs (ANDA) | September 23, 2023 |
| Ani Pharmaceuticals, Inc. | 3 | tablet | Generic drugs (ANDA) | December 16, 2022 |
| Apotex Corp. | 3 | tablet | Generic drugs (ANDA) | September 22, 2022 |
| Clinical Solutions Wholesale, LLC | 3 | tablet | Generic drugs (ANDA) | April 27, 2000 |
| Coupler LLC | 3 | tablet | Generic drugs (ANDA) | September 30, 2025 |
| NorthStar RxLLC | 3 | tablet | Generic drugs (ANDA) | October 24, 2022 |
| Sun Pharmaceutical Industries, Inc. | 3 | tablet | Generic drugs (ANDA) | April 27, 2000 |
| PD-Rx Pharmaceuticals, Inc. | 1 | tablet | Generic drugs (ANDA) | April 27, 2000 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 25 | 100% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 25 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Benzodiazepine | 25 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.